Intravaginal exposure to seminal plasma after ovum pick-up does not increase live birth rates after in vitro fertilization or intracytoplasmic sperm injection treatment: a double-blind, placebo-controlled randomized trialShow others and affiliations
2024 (English)In: Fertility and Sterility, ISSN 0015-0282, E-ISSN 1556-5653, Vol. 122, no 1, p. 131-139Article in journal (Refereed) Published
Abstract [en]
Objective: To detect whether intravaginal exposure to prepared seminal plasma led to an absolute increase in live birth rate (LBR) after in vitro fertilization (IVF) by 10% compared with placebo. It has been suggested that intravaginal deposition of seminal plasma after ovum pick -up (OPU) for IVF treatment, increases pregnancy and LBRs. Design: Double -blind, placebo-controlled prospective study. An outcome assessment was made before the type of intervention was unblinded. The outcome data were analyzed according to an intention-to-treat protocol. Setting: University Hospital. Patients: Couples scheduled for an IVF treatment cycle: in total, 792 couples (393 in the seminal plasma group and 399 in the control group) were recruited over a 5-year period of inclusion in a single -center setting. Intervention: On the day of OPU, the couples were randomized into groups receiving either vaginal deposition of prepared seminal plasma from the partner or saline. Both participants and the physician were blind to the grouping. Main Outcome Measures: The primary outcome was a live birth (LB). The secondary outcomes were a positive pregnancy test, de fi ned as human chorionic gonadotropin identi fi ed in urine 3 weeks after OPU , and clinical pregnancy, de fi ned as an intrauterine viable pregnancy assessed using transvaginal sonography after 5 - 7 weeks. Results: In the index group, 35.4% had a positive pregnancy test (relative risk [RR],0.93; 95% con fi dence interval {CI} 0.78 - 1.10), 28.8% had a clinical pregnancy (RR 1.00, 95% CI 0.97 - 1.03), and 26.5% had a LB (RR 0.86; 95% CI 0.70 - 1.07), adjusted for day of transfer, female age, and number of fertilized oocytes. Corresponding rates in the control group were 37.3%, 33.6%, and 29.8%. No statistically signi fi cant differences regarding outcomes between the two intervention groups were found. Conclusion: Prepared seminal plasma applied in the vagina directly after OPU did not increase the rates of LB or clinical pregnancies. The importance of immunological factors to allow the implantation of an embryo is not questioned, but no improvement in the LBRs in IVF treatment by introducing the male partner ' s prepared seminal plasma after OPU could be found. Clinical Trial Registration Number: Clinicaltrials.gov, ID NCT02716753. Registration date 17 March, 2016, fi rst enrollment November, 2016, completed March, 2023. (Fertil Steril (R) 2024;122:131 - 9. (c) 2024 by American Society for Reproductive Medicine.) El resumen est & aacute; disponible en Espa & ntilde;ol al final del art & iacute;culo.
Place, publisher, year, edition, pages
ELSEVIER SCIENCE INC , 2024. Vol. 122, no 1, p. 131-139
Keywords [en]
IVF; ICSI; seminal plasma; live birth rate
National Category
Gynaecology, Obstetrics and Reproductive Medicine
Identifiers
URN: urn:nbn:se:liu:diva-206672DOI: 10.1016/j.fertnstert.2024.02.002ISI: 001259092100001PubMedID: 38342372OAI: oai:DiVA.org:liu-206672DiVA, id: diva2:1891535
2024-08-222024-08-222025-04-17